Trade IDEAYA Biosciences, Inc. - IDYA CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.18 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.026235% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004012% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 36.45 |
| Open | 36.52 |
| 1-Year Change | 30.57% |
| Day's Range | 36.36 - 37.06 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 9, 2024 | 36.45 | 0.23 | 0.64% | 36.22 | 37.57 | 36.13 |
| Sep 6, 2024 | 36.13 | -1.00 | -2.69% | 37.13 | 37.56 | 35.71 |
| Sep 5, 2024 | 37.33 | -1.08 | -2.81% | 38.41 | 38.53 | 37.07 |
| Sep 4, 2024 | 38.40 | 0.72 | 1.91% | 37.68 | 38.46 | 37.52 |
| Sep 3, 2024 | 38.09 | -0.87 | -2.23% | 38.96 | 40.11 | 37.89 |
| Aug 30, 2024 | 39.44 | 1.09 | 2.84% | 38.35 | 39.47 | 38.15 |
| Aug 29, 2024 | 39.13 | -0.36 | -0.91% | 39.49 | 40.09 | 38.86 |
| Aug 28, 2024 | 39.55 | 0.59 | 1.51% | 38.96 | 39.77 | 38.63 |
| Aug 27, 2024 | 39.28 | -0.08 | -0.20% | 39.36 | 39.52 | 38.96 |
| Aug 26, 2024 | 39.76 | 0.19 | 0.48% | 39.57 | 40.64 | 39.52 |
| Aug 23, 2024 | 39.45 | 1.13 | 2.95% | 38.32 | 39.55 | 38.06 |
| Aug 22, 2024 | 38.28 | -1.29 | -3.26% | 39.57 | 39.74 | 37.96 |
| Aug 21, 2024 | 39.66 | -0.13 | -0.33% | 39.79 | 40.39 | 38.90 |
| Aug 20, 2024 | 39.46 | 0.83 | 2.15% | 38.63 | 39.52 | 37.96 |
| Aug 19, 2024 | 39.02 | 1.30 | 3.45% | 37.72 | 39.18 | 37.45 |
| Aug 16, 2024 | 37.70 | 0.43 | 1.15% | 37.27 | 38.17 | 37.27 |
| Aug 15, 2024 | 38.07 | 1.16 | 3.14% | 36.91 | 38.20 | 36.91 |
| Aug 14, 2024 | 36.71 | -1.38 | -3.62% | 38.09 | 38.16 | 36.34 |
| Aug 13, 2024 | 38.11 | 0.25 | 0.66% | 37.86 | 38.35 | 37.44 |
| Aug 12, 2024 | 37.55 | -0.06 | -0.16% | 37.61 | 38.13 | 36.75 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
IDEAYA Biosciences, Inc. Company profile
About Ideaya Biosciences Inc
IDEAYA Biosciences, Inc. is a synthetic lethality-focused precision medicine company. The Company focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The Company’s product candidate is IDE196, a protein kinase C (PKC), inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations. Its preclinical pipeline includes multiple synthetic lethality programs, including against methionine adenosyltransferase 2a (MAT2A) in tumor cells having methylthioadenosine phosphorylase (MTAP) gene deletion; Pol-theta, in tumors with genetic mutations in homologous recombination deficiency (HRD), including breast carcinoma (BRCA ) mutations; poly adenosine diphosphate-ribose glycohydrolase (PARG), in tumors with genetic mutations in BRCA or base excision repair, and Werner Helicase, in high microsatellite instability tumors (MSI) tumors.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Ideaya Biosciences Inc revenues increased 43% to $27.9M. Net loss increased 44% to $49.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and development - Balanci increase of 42% to $54.7M (expense), Stock-based Compensation in SGA increase from $1.2M to $4.7M (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
7000 Shoreline Ct Ste 350
SOUTH SAN FRANCISCO
CALIFORNIA 94080-7604
US
News
Market analysis: US CPI and PPI
Overview of upcoming US inflation data for August, with expectations for a year-over-year CPI drop to 2.6% and core CPI holding steady at 3.2%. Markets will also focus on U.S. PPI data, which is forecasted to show mild growth, reinforcing potential easing inflationary pressures.
07:56, 10 September 2024
Introducing Newsquawk: your new in-platform newsfeed
We are very excited to announce the launch of Newsquawk in the Capital.com platform and app. This new newsfeed is designed to help you get ahead with real-time headlines, personalised stories and in-depth reports – all available directly in the platform and app, where you need them.
14:09, 20 August 2024
Jackson Hole Preview: All eyes on Powell and Gold
The key focus this week will be on Jerome Powell and any insight he may give into the future of monetary policy.
15:24, 19 August 2024
All eyes on inflation: US and UK CPI take centre stage
Just over a month has gone by since the latest CPI data was released in the US and so much has happened since.
14:41, 13 August 2024
European stocks face resistance in their attempt to recover
European stocks struggle to recover as the tech sector faces continued downside pressure in Asia.
13:56, 9 August 2024
Global selloff continues on US economy fears
Thursday’s rise in jobless claims led to a market meltdown in the US stock market as investors became concerned that the Federal Reserve made the wrong decision by keeping rates unchanged on Wednesday.
14:40, 5 August 2024
FOMC PREVIEW
Markets believe the Federal reserve will continue to leave their monetary policy unchanged at the meeting next week.
14:09, 1 August 2024People also watch
Still looking for a broker you can trust?
Join the 640,000+ traders worldwide that chose to trade with Capital.com